True Grit: Talent Management from the Ground Up

How one small but fast-growing drugmaker is recruiting and managing talent through emulating the grit of its patients Founded in 2008 as a startup with only a handful of employees and no office space, Horizon Pharma now has over 1,000 employees and 11 medicines that treat rar Powered by WPeMatico Continue reading True Grit: Talent Management from the Ground Up

HBA’s Woman of the Year 2019

A Force for Change: What perhaps began as a great accident, Sharon Callahan has built a career in healthcare marketing that was seemingly destined defined by an entrepreneurial drive to advance medical communications, and a commitment to breaking down barriers in the workplace and be Powered by WPeMatico Continue reading HBA’s Woman of the Year 2019

Future Pharma: Data Science as a Strategic Partner

Leaders at Novartis share how the big pharma is laying the foundations for a potential new operating model as a “medicines and data science company” At the beginning of 2018, Novartis CEO Vas Narasimhan spoke of reimagining Novartis as a medicines and data science com Powered by WPeMatico Continue reading Future Pharma: Data Science as a Strategic Partner

EMA Relocation Countdown: Some Industry Viewpoints

July 1, 2018 marked the start of the six-month countdown to the European Medicines Agency (EMA) relocation of its operations to Amsterdam. Worryingly, there remains little guidance or clarity from the EMA as to the implications of the move, and Brexit, on the pharma industry. Three industr Powered by WPeMatico Continue reading EMA Relocation Countdown: Some Industry Viewpoints

Regulatory Information Management: Current and Future States

At this month’s AMPLEXOR Life Sciences Be The Expert conference in Dubrovnik, Croatia, Steve Gens of life sciences consultancy Gens & Associates talked about the evolution of Regulatory Information Management (RIM) and offered some predictions for 2022. Pharm Exec caught up Powered by WPeMatico Continue reading Regulatory Information Management: Current and Future States

Growth in the Time of Brexit: James Burt, Accord Healthcare

Accord Healthcare, which acquired Actavis UK and Ireland in 2017, is one of the fastest-growing generic pharmaceutical companies in the UK. It aims to become a Top 5 pan-EMENA (Europe, Middle East and North Africa) generics company by 2021 and has developed a specialty products commercialization Powered by WPeMatico Continue reading Growth in the Time of Brexit: James Burt, Accord Healthcare